Attention Deficit Disorder with Hyperactivity (definition)

encyclopedia of medical concepts

ψ	Attention Deficit Disorder with Hyperactivity

More information in Books or on

Definition: A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-IV)

not confined to children; do not confuse with HYPERKINESIS: note X refs under both; DF: ADDH or ADHD

Other names Minimal Brain Dysfunction; Hyperkinetic Syndrome; Brain Dysfunction, Minimal; Attention Deficit Hyperactivity Disorder; Attention Deficit Disorder; Syndromes, Hyperkinetic; Dysfunction, Minimal Brain; Disorders, Attention Deficit; Disorder, Attention Deficit; Deficit Disorders, Attention; Deficit Disorder, Attention; Attention Deficit Disorders; Attention Deficit Hyperactivity Disorders; Attention Deficit Disorders with Hyperactivity

Substance	CAS Registry & name	Categories	Source
lisdexamfetamine dimesylate	0	*Dextroamphetamine Attention Deficit Disorder with Hyperactivity.	http://www.rxpgnews.com/research/psychiatry/child/adhd/article_4321.shtml	VYVANSE
DOCK3 protein, human	0	Nerve Tissue Proteins Guanine Nucleotide Exchange Factors Attention Deficit Disorder with Hyperactivity.
atomoxetine	83015-26-3	Propylamines Attention Deficit Disorder with Hyperactivity. Pharma Action* Adrenergic Uptake Inhibitors	Psychopharmacology (Berlin) 1984;83(1):126	STRATTERA; ATOMOXETINE HYDROCHLORIDE

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link

Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012
Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor

We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy